Extended release formulation of etodolac

A technology of sustained-release agent and composition, applied in the field of sustained-release preparations of etodolac

Inactive Publication Date: 2005-11-16
RANBAXY LAB LTD
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This formulation is not suitable for drugs that are poorly soluble in acidic media like etodolac

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0008] The etodolac used in the present invention is preferably micronized to increase its total surface area and improve its solubility. Hydroxypropyl cellulose (HPC) is a partially substituted poly(hydroxypropyl) ether of cellulose available from Klucel under the tradename TM (Aqualon), Methocel TM (Dow Chemical Co.) and Nisso HPC TM . According to the invention, the carrier base material preferably comprises one or more viscosity grades of HPC. More preferably, the hydroxypropylcellulose is selected from viscosity grades (2% in water at 20°C) of 6.0-10.0 centipoise (HPC-L) and 150-400 centipoise (HPC-M). HPC-L is present in an amount of about 5-40% by weight of the formulation, preferably 5-20% by weight of the formulation, and HPC-M is present in an amount of about 5-25% by weight, more preferably about 5% by weight of the formulation. -15% by weight. HPC-L is a fast-swelling material that allows for controlled initial drug release from the dosage form. HPC-M control...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A sustained release formulation of etodolac for once daily administration is described.

Description

field of invention [0001] The present invention relates to sustained-release formulations of etodolac for once-daily administration. Background of the invention [0002] U.S. Patent 3,939,178 discloses etodolac (1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]-indole-1-acetic acid or its pharmaceutically acceptable of salt). It has been reported to have analgesic and anti-inflammatory properties. It can also treat gout by reducing the level of uric acid in human blood (US Patent 4,663,345), and treat rheumatoid arthritis by reducing blood rheumatoid factor (US Patent 4,742,076). [0003] Etodolac is approved to control the symptoms and symptoms of osteoarthritis, rheumatoid arthritis, and to control pain. The usual dosage is 800 mg to 1200 mg, given in 2-4 divided doses. This dosing regimen is problematic because it is very inconvenient to the patient and makes it difficult for the patient to comply. Those skilled in the art know that sustained release systems can reduce the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/20A61K9/22A61K31/407
CPCA61K31/407A61K9/2054
Inventor R・S・拉古瓦石A・朗帕尔H・森
Owner RANBAXY LAB LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap